Abstract
Atrial fibrillation (AF) is the most common sustained cardiac arrhythmia requiring medical care [1]. Dronedarone is derived from amiodarone, but has different electrophysiological effects [2,3]. Dronedarone has been approved to treat paroxysmal or persistent AF, which is associated with a reduction of AF-related hospitalization, stroke or mortality [4,5]. However, dronedarone should be avoided in patients with decompensated heart failure or permanent AF due to an increased mortality [6,7].
Full Text 
Sign-in/Register to access full text options
Sign-in/Register to access full text options 
Published version (
Free)
Free) 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a call
